Incretinblend example sentences
Related (8): incretin, exenatide, liraglutide, albiglutide, sitagliptin, vildagliptin, saxagliptin, linagliptin
"Incretinblend" Example Sentences
1. Incretinblend therapies have been associated with improved glycemic control.2. The incretinblend medications are effective in reducing blood glucose levels.
3. Many diabetics have found incretinblend drugs to be beneficial.
4. Incretinblend treatments have been found to be safe and well-tolerated.
5. Incretinblend has been shown to improve glycemic control in patients with type 2 diabetes.
6. Incretinblend may be used as an adjunct to other anti-diabetic medications.
7. Incretinblend therapy has been associated with improved glycemic control and weight loss.
8. Incretinblend has been found to be effective in reducing blood glucose levels in patients with type 2 diabetes.
9. Incretinblend has been used to reduce the risk of cardiovascular complications in patients with type 2 diabetes.
10. Incretinblend has been shown to improve glycemic control and reduce the risk of cardiovascular events in patients with type 2 diabetes.
11. Incretinblend has been found to be beneficial in controlling blood glucose levels in patients with type 2 diabetes.
12. Incretinblend therapy has been associated with improved glycemic control and a reduction in the risk of cardiovascular complications.
13. Incretinblend medications have been found to be safe and well-tolerated in patients with type 2 diabetes.
14. Incretinblend drugs have been used to reduce the risk of cardiovascular events in patients with type 2 diabetes.
15. Incretinblend has been shown to improve glycemic control and reduce the risk of cardiovascular events in patients with type 2 diabetes.
16. Incretinblend has been found to be effective in controlling blood glucose levels in patients with type 2 diabetes.
17. Incretinblend medications may be used as an adjunct to other anti-diabetic medications.
18. Incretinblend therapies have been found to be safe and well-tolerated in patients with type 2 diabetes.
19. Incretinblend has been used to reduce the risk of cardiovascular complications in patients with type 2 diabetes.
20. Incretinblend drugs may be used to improve glycemic control and reduce the risk of cardiovascular events in patients with type 2 diabetes.
21. Incretinblend has been associated with improved glycemic control and a reduction in the risk of cardiovascular complications.
22. Incretinblend may be beneficial in controlling blood glucose levels in patients with type 2 diabetes.
23. Incretinblend treatments have been found to be effective in reducing blood glucose levels in patients with type 2 diabetes.
24. Incretinblend has been used to improve glycemic control and reduce the risk of cardiovascular events in patients with type 2 diabetes.
25. Incretinblend medications have been found to be beneficial in controlling blood glucose levels in patients with type 2 diabetes.
26. Incretinblend drugs may be used as an adjunct to other anti-diabetic medications.
27. Incretinblend has been associated with improved glycemic control and weight loss in patients with type 2 diabetes.
28. Incretinblend therapies have been found to be safe and well-tolerated in patients with type 2 diabetes.
29. Incretinblend may be used to reduce the risk of cardiovascular events in patients with type 2 diabetes.
30. Incretinblend has been shown to improve glycemic control and reduce the risk of cardiovascular complications in patients with type 2 diabetes.
31. Incretinblend medications have been found to be effective in controlling blood glucose levels in patients with type 2 diabetes.
32. Incretinblend drugs may be beneficial in reducing the risk of cardiovascular events in patients with type 2 diabetes.
33. Incretinblend treatments have been associated with improved glycemic control and a reduction in the risk of cardiovascular complications.
34. Incretinblend has been used to reduce the risk of cardiovascular events in patients with type 2 diabetes.
35. Incretinblend may be beneficial in improving glycemic control and reducing the risk of cardiovascular events in patients with type 2 diabetes.
36. Incretinblend medications have been found to be safe and well-tolerated in patients with type 2 diabetes.
37. Incretinblend has been associated with improved glycemic control and weight loss in patients with type 2 diabetes.
38. Incretinblend drugs may be used as an adjunct to other anti-diabetic medications.
39. Incretinblend therapies have been found to be effective in controlling blood glucose levels in patients with type 2 diabetes.
40. Incretinblend has been shown to reduce the risk of cardiovascular events in patients with type 2 diabetes.
Common Phases
GLP-1 agonist; DPP-4 inhibitor; GLP-1/glucagon dual agonistRecently Searched
› Legateefrom noun
› Jingoisticorigin [ˈjiNGɡōˌizəm]
› Hardly adverb
› Uncom [ˌənˈkämən]
› Hatchlings noun
› Anfractuosity adjective rare
› Realtime noun
› Turnips
› Asides
› Reissue verb
› Sigurd
› Indelicates [inˈdeləkət]
› Infernals [inˈfərnl]
› Basinger
› Texture noun
› Incandescent adjective
› Wastrel noun
› Demilitarize verb
› Girde verb
› Reverberation noun